|
THAP9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.762800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.199000E-01 |
| Normal-vs-Stage2 |
7.344800E-01 |
| Normal-vs-Stage3 |
1.903190E-03 |
| Normal-vs-Stage4 |
1.50052999999817E-05 |
| Stage1-vs-Stage2 |
7.641800E-01 |
| Stage1-vs-Stage3 |
1.059410E-01 |
| Stage1-vs-Stage4 |
3.261700E-03 |
| Stage2-vs-Stage3 |
2.110600E-01 |
| Stage2-vs-Stage4 |
3.756300E-02 |
| Stage3-vs-Stage4 |
1.572610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.403300E-03 |
| Normal-vs-AfricanAmerican |
3.940200E-02 |
| Normal-vs-Asian |
5.099200E-01 |
| Caucasian-vs-AfricanAmerican |
6.722600E-01 |
| Caucasian-vs-Asian |
9.705200E-01 |
| AfricanAmerican-vs-Asian |
8.268200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.404250E-03 |
| Normal-vs-Female |
2.035000E-01 |
| Male-vs-Female |
4.279400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.542600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.401000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.9438999999939E-05 |
| Normal-vs-Age(81-100Yrs) |
2.802000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.612400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.419200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.917630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.861600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.845910E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.753200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.117200E-01 |
| Normal-vs-Grade 2 |
8.301400E-01 |
| Normal-vs-Grade 3 |
5.959200E-04 |
| Normal-vs-Grade 4 |
2.09929962302624E-10 |
| Grade 1-vs-Grade 2 |
5.394200E-01 |
| Grade 1-vs-Grade 3 |
1.131810E-01 |
| Grade 1-vs-Grade 4 |
2.639100E-04 |
| Grade 2-vs-Grade 3 |
2.271800E-02 |
| Grade 2-vs-Grade 4 |
6.20679999951967E-07 |
| Grade 3-vs-Grade 4 |
4.571300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.803800E-01 |
| Normal-vs-ccB subtype |
1.64549999959185E-07 |
| ccA subtype-vs-ccB subtype |
1.57695999999374E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.076460E-02 |
| Normal-vs-N1 |
3.013700E-02 |
| N0-vs-N1 |
2.624600E-01 |
|
|
